Company Description

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.

The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.

It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders.

Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Autonomix Medical, Inc.

Country	United States
Founded	2014
Industry	Medical Devices
Sector	Healthcare
Employees	11
CEO	Bradley Hauser

Contact Details

Address: 21 Waterway Avenue, Suite 300 The Woodlands, Texas 77380 United States
Phone	713 588 6150
Website	autonomix.com

Stock Details

Ticker Symbol	AMIX
Exchange	NASDAQ
Fiscal Year	April - March
Reporting Currency	USD
CIK Code	0001617867
CUSIP Number	05330T106
ISIN Number	US05330T2050
Employer ID	47-1607810
SIC Code	3841

Key Executives

Name	Position
Bradley Hauser	President, Chief Executive Officer and Director
Walter V. Klemp	Executive Chairman
Lori H. Bisson	Executive Vice Chairman
Dr. Robert Schwartz M.D.	Co-Founder and Chief Medical Officer
Landy Toth	Co-Founder and Chief Technology Officer
Trent N. Smith CPA	Executive Vice President and Chief Financial Officer
Jennifer Cook	Chief Business Officer

Latest SEC Filings

Date	Type	Title
Aug 13, 2025	10-Q	Quarterly Report
Jul 28, 2025	10-K/A	[Amend] Annual report
Jul 23, 2025	424B3	Prospectus
Jul 22, 2025	8-K	Current Report
Jul 11, 2025	EFFECT	Notice of Effectiveness
Jul 3, 2025	POS AM	Post-Effective amendments for registration statement
May 29, 2025	10-K	Annual Report
Apr 30, 2025	8-K	Current Report
Mar 11, 2025	EFFECT	Notice of Effectiveness
Mar 7, 2025	S-3/A	[Amend] Registration statement under Securities Act of 1933

View All SEC Filings